Molluscum Contagiosum Treatment
For symptomatic molluscum contagiosum, physical destruction methods—specifically incision and curettage (aggressive enough to cause bleeding), simple excision with cautery, or cryotherapy—are the recommended first-line treatments, while observation without intervention is appropriate for asymptomatic cases given the self-limited nature of the infection. 1, 2
Treatment Algorithm Based on Clinical Context
For Symptomatic Patients (Cosmetically Bothersome, Ocular Involvement, or Underlying Skin Conditions)
Physical Destruction Methods:
- Incision and curettage (must be aggressive enough to cause bleeding to be effective)
- Simple excision with cautery
- Cryotherapy with liquid nitrogen
These physical modalities are supported by the most recent ophthalmology guidelines (2024) 1 and have been the standard approach across multiple guideline sources. When treating multiple lesions, identify and treat nascent lesions to reduce recurrence risk—reducing viral load allows the host immune response to eliminate residual virus 1, 2.
Important Caveat for Cryotherapy: While effective, cryotherapy carries risk of postinflammatory hyperpigmentation or scarring, particularly in children and patients with darker skin types 3.
For Cosmetically Sensitive Areas or Patients with Eczema
Topical Chemical Treatments:
- 10% potassium hydroxide (KOH): Demonstrated efficacy with OR 10.02 (95% CI 4.64-21.64) compared to placebo 4
- Podophyllotoxin: Strong efficacy with OR 10.24 (95% CI 3.36-31.21) 4
Both KOH and cryotherapy show similar efficacy in children 3, making either reasonable depending on patient tolerance and clinical setting.
For Asymptomatic, Immunocompetent Patients
Observation is justified given spontaneous resolution typically occurs in 6-12 months, though complete resolution can take up to 4 years 3. This "watch and wait" approach is explicitly supported by guidelines, particularly in children where physical treatments may be frightening or difficult to perform.
Special Populations
Ocular/Periocular Lesions
Treatment to remove lesions is indicated when symptomatic (causing conjunctivitis or keratitis from viral shedding) 1, 2. The conjunctivitis may require weeks to resolve after lesion elimination. Physical destruction methods remain first-line.
Immunocompromised Patients (HIV, Organ Transplant Recipients)
Large and multiple molluscum lesions with relatively little conjunctival inflammation indicate immunocompromised state 1, 2. These patients develop severe and recalcitrant lesions requiring more aggressive treatment 5. Consider:
- Cidofovir
- Imiquimod
- Interferon
Referral to dermatology is necessary for examination of suspicious lesions 1, 2.
Pregnant Patients
Physical procedures (cryotherapy) are safe 5.
Treatments NOT Recommended
Imiquimod: Not shown to be of benefit compared to placebo in randomized controlled trials 3
Ingenol mebutate: Despite showing the highest efficacy (OR 117.42) in network meta-analysis 4, safety concerns have been reported and it should not be used.
Cantharidin: While open-label studies suggest efficacy, a small randomized controlled trial showed improvement greater than placebo but not statistically significant 3. However, newer standardized preparations (VP-102) show promise in phase III trials 6.
Emerging Treatments
Two experimental topical drugs have shown promising phase III results but are not yet FDA-approved 6:
- VP-102 (standardized cantharidin preparation)
- SB206 (berdazimer, topical nitric oxide-releasing product)
These may become first FDA-approved therapies for molluscum contagiosum.
Key Clinical Pitfalls
Don't undertreate multiple lesions: Identify and treat nascent lesions to reduce recurrence—partial treatment allows viral persistence 1, 2
Don't ignore immunocompromised status: Multiple large lesions with minimal inflammation warrant HIV testing and evaluation for immunosuppression 1, 2
Don't use topical antivirals alone: They have not been shown helpful for molluscum (this applies to VZV, not molluscum specifically, but highlights the viral-specific nature of treatments) 1
Consider psychosocial impact: While observation is medically appropriate for asymptomatic cases, the "watch and wait" approach increases transmission risk and can cause anxiety, embarrassment, and isolation—active treatment may be preferred even when not strictly medically necessary 7
Screen for STIs: Patients with genital molluscum should be offered screening for other sexually transmitted infections 5